NCT05462795Completed
Liquid Biopsy for Early Non-small Lung Cancer Detection
Liquid Biopsy to Distinguish Malignant From Benign Pulmonary Nodules and to Monitor Response to Therapy
Source: ClinicalTrials.gov · Last updated 16 Dec 2024
Brief summary (registry, in English)
This clinical trial will assess the performance of a liquid biopsy assay to identify cancer in indeterminant pulmonary nodules identified by CT screening of high-risk individuals and evaluate the capability of the liquid biopsy assay to monitor response to surgical resection.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 171 (actual)
- First submitted
- 13 Jul 2022
- Start date
- 2 Aug 2022
- Primary completion date
- 22 Mar 2024
- Lead sponsor
- University of Arizona
- Diseases
- Lung cancer
- NCT number
- NCT05462795
What you commit to
- Study type: Observational
- Participants enrolled: 171
- From 2 Aug 2022 to the primary completion date, 22 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Indeterminate pulmonary nodule study cohort
- Inclusion criteria: Patients undergoing a biopsy of an indeterminate lung nodule by surgical excision, bronchoscopic biopsy or Interventional Radiology directed biopsy
- Exclusion criteria: No known concurrent cancer
- Known lung cancer for surgical resection study cohort
- Inclusion criteria: Patients with known non-small cell lung cancer who will have surgical resection for treatment
- Exclusion criteria: N/A
- Healthy volunteer cohort
- Inclusion criteria: Healthy persons
- Exclusion criteria: No known current cancer or history of cancer within 5 years
- Benign lung disease cohort
- Inclusion criteria: Patients with the following categories of benign lung disease: COPD/emphysema, Granulomatous infection, Interstitial lung disease including pulmonary fibrosis and interstitial lung disease.
- Exclusion criteria: N/A
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Arizona Coordinator of this site? Confirm its status | Tucson | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.